Ardent Health (NYSE:ARDT - Get Free Report) was upgraded by analysts at Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating in a research report issued to clients and investors on Friday,Weiss Ratings reports.
A number of other research analysts also recently commented on ARDT. Wall Street Zen raised Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. The Goldman Sachs Group began coverage on Ardent Health in a report on Tuesday, October 14th. They set a "neutral" rating and a $19.00 target price on the stock. JPMorgan Chase & Co. reduced their target price on Ardent Health from $18.00 to $15.00 and set a "neutral" rating on the stock in a report on Monday, August 11th. KeyCorp reduced their target price on Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a report on Thursday, August 7th. Finally, Bank of America downgraded Ardent Health from a "neutral" rating to an "underperform" rating and reduced their target price for the stock from $15.50 to $14.60 in a report on Wednesday, July 16th. Nine analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $19.30.
Read Our Latest Stock Analysis on ARDT
Ardent Health Stock Up 2.8%
Shares of ARDT stock traded up $0.42 during trading hours on Friday, reaching $15.23. The company had a trading volume of 400,789 shares, compared to its average volume of 394,582. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13. Ardent Health has a twelve month low of $10.10 and a twelve month high of $18.85. The company has a market capitalization of $2.18 billion, a P/E ratio of 8.41, a price-to-earnings-growth ratio of 6.56 and a beta of 0.39. The stock's fifty day simple moving average is $13.43 and its 200 day simple moving average is $13.15.
Ardent Health (NYSE:ARDT - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.22. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, sell-side analysts expect that Ardent Health will post 1.23 earnings per share for the current fiscal year.
Institutional Trading of Ardent Health
Large investors have recently added to or reduced their stakes in the business. CWM LLC increased its position in Ardent Health by 990.6% in the 2nd quarter. CWM LLC now owns 2,203 shares of the company's stock valued at $30,000 after acquiring an additional 2,001 shares during the period. Morse Asset Management Inc acquired a new stake in Ardent Health in the 1st quarter valued at approximately $36,000. Quarry LP increased its position in Ardent Health by 1,519.4% in the 1st quarter. Quarry LP now owns 5,020 shares of the company's stock valued at $69,000 after acquiring an additional 4,710 shares during the period. KLP Kapitalforvaltning AS acquired a new stake in Ardent Health in the 3rd quarter valued at approximately $80,000. Finally, New York State Common Retirement Fund increased its position in Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company's stock valued at $85,000 after acquiring an additional 3,400 shares during the period.
About Ardent Health
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.